Neuroblastoma is a rare type of cancer that occurs in the nervous system, generally in infants and young children. The cells that develop in the nervous system and give rise to neuroblastoma are medically called neuroblasts, while the nervous system that controls involuntary body functions is called the sympathetic nervous system. Affecting usually the young children/ infants, Neuroblastoma is one of the most frequently diagnosed cancers in early childhood.
This cancer usually begins in the adrenal glands, which are located above the kidneys, but it may also develop in nerve tissue along the vertebral column in the neck, chest, stomach, or pelvis. Because neuroblasts are present in several areas of the body during fetal development, tumors may arise in different locations. The abdomen is the most common site, followed by the chest and neck.
Neuroblastoma is known for its highly variable behavior. Sometimes the tumor develops slowly and may even get smaller or disappear without treatment, especially in infants. In other cases, the disease may grow aggressively and spread rapidly to other parts of the body, such as the lymph nodes, bones, bone marrow, liver, and skin.
There have been several advancements made in pediatric oncology regarding the diagnosis, therapy, and management of the condition that have greatly enhanced the chances of survival of children with neuroblastoma. Treatment strategies depend on the child's age, staging, and the biological characteristics of the disease.
The nervous system is divided into two major parts: the peripheral nervous system and the central nervous system (CNS). The sympathetic nervous system, which is part of the peripheral nervous system, controls automatic body functions, such as the “fight or flight” response.
During fetal development, immature nerve cells called neuroblasts form and mature into nerve tissue and adrenal gland cells in children; however, certain neuroblasts fail to mature normally, continuing to grow and divide uncontrollably, forming tumors. Such a type of tumor is known as neuroblastoma.
Because neuroblasts migrate throughout the body during development, neuroblastoma can occur in various locations along the sympathetic nerve chain. The tumor may remain localized in one area or spread to distant organs.
The behavior of neuroblastoma varies widely depending on the genetic/hereditary and biological characteristics of the tumor cells.
Neuroblastoma can develop in several areas of the body. The most common sites include:
Because these tumors can grow in deep tissues, they may become quite large before symptoms appear.
The symptoms of neuroblastoma differ/vary depending on the tumor’s location and whether the cancer has spread.
Common symptoms include:
Because many of these symptoms can resemble common childhood illnesses, medical evaluation is necessary if symptoms persist.
Neuroblastoma develops when genetic changes occur in immature nerve cells during early development.
These mutations cause abnormal cells to grow uncontrollably rather than mature into normal nerve cells.
In most cases, the cause of these mutations is unknown.
Although the exact causes remain unclear, certain factors may increase the risk.
Neuroblastoma occurs primarily in children under the age of five.
Only a few cases arise from genetic susceptibility.
If the child comes from a family with a history of neuroblastoma, there may be an increased chance of developing the disease.
Nevertheless, most cases develop without any genetic cause.
Early diagnosis of neuroblastoma is important for determining the best treatment strategy.
Doctors may use several tests to confirm the diagnosis.
Doctors will check the child for lumps and swelling that could be an indication of the tumor.
These tests/check-ups will help the doctor determine the tumor's position and size.
The imaging tests that doctors use include:
These check-ups/tests provide detailed images of internal structures.
An MIBG scan uses a radioactive substance that is absorbed by neuroblastoma cells. This test helps detect tumors and determine whether the cancer has spread.
A biopsy removes a small sample of tumor tissue for examination under a microscope.
This test confirms the diagnosis and helps identify specific biological characteristics of the tumor.
Bone marrow aspiration and biopsy become necessary to determine whether the cancer has spread to the bone marrow.
Blood and urine tests may detect substances produced by neuroblastoma cells, such as catecholamines.
These markers help support the diagnosis and monitor treatment response.
Staging reveals the situation, describing how far the cancer has spread in the body.
The stage of neuroblastoma is determined using imaging studies, biopsy results, and other tests.
Stages generally include:
The stage of the disease plays a major role in determining treatment options.
In addition to staging, doctors classify neuroblastoma into risk groups based on factors such as:
Patients are generally categorized into low-risk, intermediate-risk, or high-risk groups.
This classification helps guide treatment decisions.
Treatment for neuroblastoma depends on the stage and risk classification of the disease.
Treatment plans need a combination of therapies.
Surgery is commonly used to remove localized tumors.
If the tumor can be safely removed, surgery may be the only treatment required for low-risk cases.
Chemotherapy uses drugs to destroy cancer cells.
It may be used:
Radiation therapy needs high-energy beams to destroy cancer cells.
It may be used when tumors cannot be completely removed or when cancer spreads to certain areas.
For high-risk neuroblastoma, high-dose chemotherapy followed by stem cell transplantation is considered an effective option to replace damaged/impaired bone marrow with healthy stem cells.
Immunotherapy encourages the immune system to attack cancer cells.
Certain immunotherapy drugs target proteins on neuroblastoma cells, helping the immune system destroy them.
Targeted therapies focus on specific genetic changes within tumor cells.
These treatments help block signals that promote tumor growth.
Some treatments encourage immature cancer cells to mature into normal nerve cells, slowing tumor growth.
Children receiving treatment can benefit from supportive care such as:
These things will make the child feel more comfortable.
The outlook for children with neuroblastoma varies depending on several factors.
These include:
Children with low-risk neuroblastoma often have excellent survival rates. High-risk disease is more difficult to treat, but advances in therapy continue to improve results.
Regular medical check-ups and follow-ups are necessary to monitor for recurrence and manage the long-term effects of treatment.
A diagnosis of neuroblastoma can be overwhelming for families. Children undergoing treatment may face physical and emotional challenges.
Support from healthcare providers, family members, and support groups is important during treatment and recovery.
Children who successfully complete treatment require ongoing follow-up care to monitor growth, development, and long-term health.
Tender Palm Super-Speciality Hospital offers advanced Neuroblastoma treatment in Lucknow, India, at an affordable cost. We have a team of experienced pediatric oncologists and surgical specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, chemotherapy, and immunotherapy. Our Pediatric Oncology and Surgical Care team has decades of experience in successfully treating Neuroblastoma in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com